nvs
☆    

India,
2008-02-19 08:11
(6343 d 22:10 ago)

(edited on 2008-02-19 21:46)
Posting: # 1621
Views: 3,610
 

 Type of studies etc. [Dissolution / BCS / IVIVC]

Post reply
Dear all,
Anybody let me know about flow for in-vitro studies, In which stage of drug designing we have to take approval for in-vitro studies for both innovative & generic drugs.
Which parameters we have to do?
Do we conduct in-vitro studies separately with different mechanism (different in-vitro parameters) for generic & innovative drugs.
What are the common parameters for generic & innovative drugs (in in-vitro studies)
pz share any guidelines regarding this.

--
Edit: Category changed. [Ohlbe]
Edit: Subject line altered. [Helmut]
 
UA Flag
Activity
 Admin contact
23,425 posts in 4,928 threads, 1,683 registered users;
38 visitors (0 registered, 38 guests [including 13 identified bots]).
Forum time: 07:22 CEST (Europe/Vienna)

You can do one of two things; just shut up,
which is something I don’t find easy,
or learn an awful lot very fast,
which is what I tried to do.    Jane Fonda

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5